you can't create a new drug by running a model on a laptop. You can't serve a customer support bot running on a laptop. You can't generate video in bulk for many users on a laptop. So there is still a case for paying others for inference.
Does it justify the valuations? No idea, but some major use cases are still there. That's why they are rushing to implement, OpenAI creating a "deployment company", Anthropic having some pharma rumors, etc.
you can't create a new drug by running a model on a laptop. You can't serve a customer support bot running on a laptop. You can't generate video in bulk for many users on a laptop. So there is still a case for paying others for inference.
Does it justify the valuations? No idea, but some major use cases are still there. That's why they are rushing to implement, OpenAI creating a "deployment company", Anthropic having some pharma rumors, etc.